Sentences with phrase «new pharmaceutical drugs»

She directed the launch of more than 20 new pharmaceutical drugs.

Why does GlaxoSmithKline have an exclusive on the newest pharmaceutical drug that does X?

Then the animals receive a new pharmaceutical drug or treatment to see how well it alleviates the symptoms of their induced illness.

We know how to demonstrate when drug manufacturers overlook safety concerns in a rush to beat their competitors in the launch of a new pharmaceutical drug.

Not exact matches

A new study published in the New England Journal of Medicine finds that Valeant Pharmaceuticals» infamous price hikes for a pair of heart drugs called nitroprusside and isoproterenol — whose prices were increased by 310 % and 720 %, respectively — had significant downstream effects on patient canew study published in the New England Journal of Medicine finds that Valeant Pharmaceuticals» infamous price hikes for a pair of heart drugs called nitroprusside and isoproterenol — whose prices were increased by 310 % and 720 %, respectively — had significant downstream effects on patient caNew England Journal of Medicine finds that Valeant Pharmaceuticals» infamous price hikes for a pair of heart drugs called nitroprusside and isoproterenol — whose prices were increased by 310 % and 720 %, respectively — had significant downstream effects on patient care.

Valeant has been at the center of a political firestorm over prescription medication costs and pharmaceutical companies, which depend more on acquiring or licensing existing therapies (and then raising their prices) rather than fueling R&D into new drugs.

Fast forward to 1996, and the New York City - based pharmaceutical giant scored a critical patent for the revolutionary drug.

• Biohaven Pharmaceuticals, a New Haven, Conn. - based neurological disease drug developer, set terms for its IPO.

On Wednesday, Swiss pharmaceutical giant Novartis made history as the first company to win Food and Drug Administration (FDA) approval for a groundbreaking new type of cancer treatment known as CAR - T.

Recent Projects: researching number of burglar - alarm systems installed in homes and businesses (three hours» work, $ 250); pricing new drug for pharmaceutical company.

As I've previously reported, Roivant and its federation of biopharma companies focused on developing drugs in specific disease spaces is attempting a very new form of pharmaceutical R&D.

Earlier this week, Hillary Clinton released a new campaign ad targeting Valeant Pharmaceuticals (vrx) and its drug price increases.

Bristol's $ 2.4 billion purchase of Medarex — which pharmaceutical analysts routinely cite as one of the best acquisitions in the history of the industry — would give the company not only a new blockbuster but also a leadership position in a burgeoning drug category: immuno - oncology.

Many major pharmaceutical companies have stopped developing new antibiotics, and the drugs that are still in development have faced numerous stumbling blocks toward approval.

I hope so, particularly in light of pharmaceutical companies frequently pointing to the high costs of developing new drugs as being the primary reason prices are so high for existing drugs.

February 2015: Launches new company, Turing Pharmaceuticals, which acquires an old drug and jacks up their prices.

The New York Times called her pharmaceutical product the drug of a generation and Fortune called her a tireless force of nature.

In the letter, the antitrust bureau chief for New York Attorney General Eric Schneiderman asked Shkreli to contact the office «immediately» to respond to concerns that the company's sales practices were intended to deter generic pharmaceutical firms from creating alternatives to the drug.

Turing Pharmaceuticals was warned by New York's attorney general that the distribution network for a rarely used drug, whose 55-fold overnight price hike drew widespread criticism, may violate antitrust laws.

Turing Pharmaceuticals of New York bought the drug from Impax Laboratories in August for $ 55 million and raised the price.

While most of the attention on pharmaceutical prices has been on new drugs for diseases like cancer, hepatitis C and high cholesterol, there is also growing concern about huge price increases on older drugs, some of them generic, that have long been mainstays of treatment.

NEW YORK (AP)- Biotech drugmaker Amgen will buy cancer drug maker Onyx Pharmaceuticals for about $ 10.4 billion in cash in a deal that will add several cancer drugs to Amgen's stable and boost its pipeline of new druNEW YORK (AP)- Biotech drugmaker Amgen will buy cancer drug maker Onyx Pharmaceuticals for about $ 10.4 billion in cash in a deal that will add several cancer drugs to Amgen's stable and boost its pipeline of new drunew drugs.

Interviews with former Sprout employees, analysts, investors and doctors who helped bring the drug to market suggest how a series of missteps after the deal, along with turbulence from aggressive accounting practices, unusual business relationships and big egos, derailed one of the most intriguing new pharmaceuticals in a generation.

Drug companies often face the need to come up with new medicines, especially as patents on older pharmaceuticals expire.

(Reuters)- Alnylam Pharmaceuticals Inc's RNAi - based drug that targets a rare genetic disease met the main goal of a key study, in a breakthrough for the new class of medicines that works by blocking disease - causing proteins.

No. 1: Medical marijuana laws are passed, but GW Pharmaceuticals shares will continue to drop Admittedly, this is a new spin on my 2015 prediction that shares in marijuana drug developer GW Pharmaceuticals plc (NASDAQ: GWPH) would fall because of trial failures.

Brian Feroldi (ACADIA Pharmaceuticals): Introducing a new drug to the market can be challenging, but the odds of success go up when there isn't any competition to worry about.

Since the late 1950s, DuPont had conducted pharmaceuticals research but found that it lacked the experience necessary to expedite FDA approval for new drugs and then market them.

In anticipation of an effort to acquire new drug companies, Endo was renamed DuPont Pharmaceuticals in 1982.

Andrew observed a very dangerous trend taking hold: Doctors — who were having new drugs pushed to them by profit - driven pharmaceutical companies — began prescribing extremely powerful and addictive opioid painkillers to patients with almost reckless abandon.

Also, if a pharmaceutical agent like GHRP - 6 is indicated for a skin condition there will be numerous studies and a new drug application to review.

Nevada and five other states are filing new lawsuits accusing a Connecticut - based pharmaceutical company of using deceptive marketing to boost drug sales that fueled opioid overdose deaths.

The budget also proposes new mandates on business, such as a requirement that a pharmaceutical manufacturer provides a minimum supplemental rebate for drugs that are eligible for state public health plan reimbursement.

Gov. Andrew Cuomo should veto a bill passed by the New York State Legislature that blocks local governments from billing pharmaceutical companies to dispose of unused prescription drugs.

Onondaga County has filed a lawsuit against multiple prescription drug manufacturers and distributors, joining other New York counties who in recent months have demanded pharmaceutical companies pay for costs of the growing opioid crisis.

Many thousands more papers remain sealed as part of ongoing lawsuits brought by more than 14,000 women against the drug maker Wyeth, which was bought last year by the pharmaceutical giant Pfizer, based in New York.

In the intervening years, another company — Marathon Pharmaceuticals — acquired the rights to the deflazacort and began a new push to gain FDA approval for the drug.

A new broad range antibiotic, developed jointly by scientists at The Rockefeller University and Astex Pharmaceuticals, has been found to kill a wide range of bacteria, including drug - resistant Staphylococcus (MRSA) bacteria that do not respond to traditional drugs.

Identifying the chemicals and networks that catalyze remission in type 2 diabetes would be a far more transformative advance, since it would help lead pharmaceutical companies toward new anti-diabetes drugs.

Recalls of Cox - 2 inhibitor drugs during the past year have raised questions about the credibility of the U.S. Food and Drug Administration's (FDA's) regulation of new drugs and suspicions that pharmaceutical companies have been overly eager to put fresh remedies on the market.

Last January, as new H1N1 flu infections were trailing off in the Northern Hemisphere, accusations began to fly that the World Health Organization's declaration of a pandemic in the spring of 2009 had served mainly to line the pockets of pharmaceutical companies making vaccines and the drug Tamiflu.

Today, job prospects within computational biology — also known as bioinformatics — seem strong and appear to be growing, buoyed by pharmaceutical and biotech industries looking to take advantage of reams of genomics data and usher in a new era of drug discovery.

Two years ago the pharmaceutical giant GlaxoSmithKline purchased Sirtris for $ 720 million, and by August of last year The New York Times was speculating that compounds capable of activating sirtuin genes were now the leading candidates for what the newspaper called «the ultimate free lunch... a drug that tricks the body into thinking it is on [a calorie - restricted] diet.»

A 2013 joint report from epilepsy research organizations explained that «because the marketplace is already awash with [antiseizure drugs], many pharmaceutical companies now refrain from the expensive enterprise of developing new compounds.»

«If a cosmetics company wants to add a new fragrance to its products or a pharmaceutical company needs to change the active ingredients of a drug, they need to add new chemical compounds,» Grier explains.

He says such a tool could be useful for pharmaceutical chemists who want to mix and match chemical building blocks in many ways to search for new drugs — another application the researchers are working on.

In a new study, published in International Journal of Pharmaceutics, the researchers show that the extremely porous magnesium carbonate Upsalite may provide a great potential for the development of new drug formulations of active pharmaceutical ingredients with poor aqueous solubility.

«An industry scientist, Bill Sheridan of BioCryst Pharmaceuticals Inc., which is headquartered in Durham, North Carolina, cautioned that new flu drugs must be tested on wild strains to look for resistance, which is one way of enhancing a virus,» Kaiser wrote.

These drugs subsequently have low bioavailability (i.e., they are difficult for the body to take up), which limit their therapeutic efficacy and hence seldom leads to new pharmaceuticals.

Working with researchers from the Danish pharmaceutical company, H.Lundbeck A / S, they tested a new drug that targets the Parkinson's mutation in flies.